{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:47:13Z","timestamp":1780706833550,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics & Neonatology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.pedneo.2024.03.013","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T19:26:53Z","timestamp":1724095613000},"page":"223-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Insights into clinical phenotypes and treatment responses in a Small cohort of Taiwanese patients with SCN1A variants: A Preliminary study"],"prefix":"10.1016","volume":"66","author":[{"given":"Yu Min","family":"Syu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inn\u2010Chi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyh-Feng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pi-Lien","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syuan-Yu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3085-0298","authenticated-orcid":false,"given":"Jao-Shwann","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2024.03.013_bib1","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/brain\/awm002","article-title":"The spectrum of SCN1A-related infantile epileptic encephalopathies","volume":"130","author":"Harkin","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.pedneo.2024.03.013_bib2","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1212\/WNL.57.12.2265","article-title":"Partial and generalized epilepsy with febrile seizures plus and a novel SCN1A mutation","volume":"57","author":"Abou-Khalil","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pedneo.2024.03.013_bib3","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1111\/j.1528-1167.2010.02645.x","article-title":"Partial epilepsy with antecedent febrile seizures and seizure aggravation by antiepileptic drugs: associated with loss of function of Na(v) 1.1","volume":"51","author":"Liao","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.pedneo.2024.03.013_bib4","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/jmg.2009.074328","article-title":"Mechanisms for variable expressivity of inherited SCN1A mutations causing Dravet syndrome","volume":"47","author":"Depienne","year":"2010","journal-title":"J Med Genet"},{"key":"10.1016\/j.pedneo.2024.03.013_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1103","article-title":"Modifier genes in SCN1A-related epilepsy syndromes","volume":"8","author":"de Lange","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.pedneo.2024.03.013_bib6","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1212\/WNL.0000000000004384","article-title":"Genetic epilepsy with febrile seizures plus: refining the spectrum","volume":"89","author":"Zhang","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.pedneo.2024.03.013_bib7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/epi4.12413","article-title":"A retrospective review of changes and challenges in the use of antiseizure medicines in Dravet syndrome in Norway","volume":"5","author":"Heger","year":"2020","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.pedneo.2024.03.013_bib8","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/epi.17274","article-title":"International consensus on diagnosis and management of Dravet syndrome","volume":"63","author":"Wirrell","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.pedneo.2024.03.013_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cca.2013.02.015","article-title":"Molecular aspects of Dravet syndrome patients in Taiwan","volume":"421","author":"Lin","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pedneo.2024.03.013_bib10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.braindev.2014.10.003","article-title":"Electroencephalographic features of patients with SCN1A-positive Dravet syndrome","volume":"37","author":"Lee","year":"2015","journal-title":"Brain Dev"},{"key":"10.1016\/j.pedneo.2024.03.013_bib11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the international League against epilepsy: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.pedneo.2024.03.013_bib12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1684\/epd.2018.0985","article-title":"Genetic literacy series: genetic epilepsy with febrile seizures plus","volume":"20","author":"Myers","year":"2018","journal-title":"Epileptic Disord"},{"issue":"Suppl 9","key":"10.1016\/j.pedneo.2024.03.013_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1528-1157.2000.tb02210.x","article-title":"Severe myoclonic epilepsy in infants and its related syndromes","volume":"41","author":"Dravet","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.pedneo.2024.03.013_bib14","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.4172\/Neuropsychiatry.1000494","article-title":"Genetic diagnosis in children with epilepsy and developmental delay\/mental retardation using targeted gene panel analysis","volume":"8","author":"Liang","year":"2018","journal-title":"Neuropsychiatry"},{"key":"10.1016\/j.pedneo.2024.03.013_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.nbd.2012.10.016","article-title":"CACNA1A variants may modify the epileptic phenotype of Dravet syndrome","volume":"50","author":"Ohmori","year":"2013","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pedneo.2024.03.013_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.nbd.2008.07.017","article-title":"A CACNB4 mutation shows that altered Ca(v)2.1 function may be a genetic modifier of severe myoclonic epilepsy in infancy","volume":"32","author":"Ohmori","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pedneo.2024.03.013_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000649","article-title":"A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome","volume":"5","author":"Singh","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.pedneo.2024.03.013_bib18","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/epi.12256","article-title":"Dravet syndrome: new potential genetic modifiers, imaging abnormalities, and ictal findings","volume":"54","author":"Gaily","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.pedneo.2024.03.013_bib19","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1093\/hmg\/ddm248","article-title":"The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy","volume":"16","author":"Martin","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pedneo.2024.03.013_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.yebeh.2018.09.041","article-title":"Outcomes and comorbidities of SCN1A-related seizure disorders","volume":"90","author":"de Lange","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.pedneo.2024.03.013_bib21","doi-asserted-by":"crossref","first-page":"eaay6848","DOI":"10.1126\/scitranslmed.aay6848","article-title":"Predicting functional effects of missense variants in voltage-gated sodium and calcium channels","volume":"12","author":"Heyne","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.pedneo.2024.03.013_bib22","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/brain\/awac210","article-title":"The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications","volume":"145","author":"Brunklaus","year":"2022","journal-title":"Brain"},{"issue":"Suppl 3","key":"10.1016\/j.pedneo.2024.03.013_bib23","first-page":"S25","article-title":"SCN1A\/NaV 1.1 channelopathies: mechanisms in expression systems, animal models, and human iPSC models","volume":"60","author":"Mantegazza","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.pedneo.2024.03.013_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/epi4.12281","article-title":"Autism spectrum disorder and cognitive profile in children with Dravet syndrome: delineation of a specific phenotype","volume":"4","author":"Ouss","year":"2018","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.pedneo.2024.03.013_bib25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/jhg.2016.5","article-title":"Establishment of isogenic iPSCs from an individual with SCN1A mutation mosaicism as a model for investigating neurocognitive impairment in Dravet syndrome","volume":"61","author":"Maeda","year":"2016","journal-title":"J Hum Genet"},{"key":"10.1016\/j.pedneo.2024.03.013_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78218-0","article-title":"Cognitive performance and behavior across idiopathic\/genetic epilepsies in children and adolescents","volume":"10","author":"Moorhouse","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.pedneo.2024.03.013_bib27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng.835","article-title":"Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations","volume":"43","author":"O'Roak","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.pedneo.2024.03.013_bib28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nature10989","article-title":"Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations","volume":"485","author":"O\u2019Roak","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pedneo.2024.03.013_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pediatrneurol.2017.01.025","article-title":"Optimizing the diagnosis and management of Dravet syndrome: recommendations from a north American consensus panel","volume":"68","author":"Wirrell","year":"2017","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.pedneo.2024.03.013_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eplepsyres.2014.10.014","article-title":"Efficacy and tolerability of the ketogenic diet in Dravet syndrome - comparison with various standard antiepileptic drug regimen","volume":"109","author":"Dressler","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pedneo.2024.03.013_bib31","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1111\/j.1528-1167.2009.02179.x","article-title":"Stiripentol open study in Japanese patients with Dravet syndrome","volume":"50","author":"Inoue","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.pedneo.2024.03.013_bib32","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pedneo.2024.03.013_bib33","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(00)03157-3","article-title":"Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group","volume":"356","author":"Chiron","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pedneo.2024.03.013_bib34","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jamaneurol.2019.4113","article-title":"Fenfluramine for treatment-resistant seizures in patients with Dravet syndrome receiving stiripentol-inclusive regimens: a randomized clinical trial","volume":"77","author":"Nabbout","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.pedneo.2024.03.013_bib35","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(19)32500-0","article-title":"Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial","volume":"394","author":"Lagae","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.pedneo.2024.03.013_bib36","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/brain\/awac210","article-title":"The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications","volume":"145","author":"Brunklaus","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.pedneo.2024.03.013_bib37","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1212\/WNL.0000000000004331","article-title":"Not all SCN1A epileptic encephalopathies are Dravet syndrome: Early profound Thr226Met phenotype","volume":"89","author":"Sadleir","year":"2017","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1016\/j.pedneo.2024.03.013_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1528-1167.2011.02996.x","article-title":"Electroencephalographic characteristics of Dravet syndrome","volume":"52","author":"Bureau","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.pedneo.2024.03.013_bib39","doi-asserted-by":"crossref","first-page":"E904","DOI":"10.1002\/humu.21083","article-title":"The SCN1A variant database: a novel research and diagnostic tool","volume":"30","author":"Claes","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pedneo.2024.03.013_bib40","unstructured":"National Center for Biotechnology Information. ClinVar; [VCV000068505.34]. Available at https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/VCV000068505.34 Accessed January 5, 2024.."},{"key":"10.1016\/j.pedneo.2024.03.013_bib41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and Genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.pedneo.2024.03.013_bib42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/0883073813509016","article-title":"Broad phenotypic heterogeneity due to a novel SCN1A mutation in a family with genetic epilepsy with febrile seizures plus","volume":"29","author":"Goldberg-Stern","year":"2014","journal-title":"J Child Neurol"},{"key":"10.1016\/j.pedneo.2024.03.013_bib43","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJMoa0910752","article-title":"Timing of de novo mutagenesis--a twin study of sodium-channel mutations","volume":"363","author":"Vadlamudi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pedneo.2024.03.013_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41588-020-00755-1","article-title":"Differences between germline genomes of monozygotic twins","volume":"53","author":"Jonsson","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.pedneo.2024.03.013_bib45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13073-014-0060-z","article-title":"Epigenetics of discordant monozygotic twins: implications for disease","volume":"6","author":"Castillo-Fernandez","year":"2014","journal-title":"Genome Med"},{"key":"10.1016\/j.pedneo.2024.03.013_bib46","doi-asserted-by":"crossref","first-page":"10604","DOI":"10.1073\/pnas.0500398102","article-title":"Epigenetic differences arise during the lifetime of monozygotic twins","volume":"102","author":"Fraga","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pedneo.2024.03.013_bib47","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1093\/hmg\/ddr416","article-title":"Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder","volume":"20","author":"Dempster","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pedneo.2024.03.013_bib48","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1111\/epi.13649","article-title":"De novo SCN1A pathogenic variants in the GEFS+ spectrum: not always a familial syndrome","volume":"58","author":"Myers","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.pedneo.2024.03.013_bib49","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/jhg.2010.39","article-title":"Analysis of SCN1A mutation and parental origin in patients with Dravet syndrome","volume":"55","author":"Sun","year":"2010","journal-title":"J Hum Genet"},{"key":"10.1016\/j.pedneo.2024.03.013_bib50","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/gim.2017.114","article-title":"High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders","volume":"20","author":"Stosser","year":"2018","journal-title":"Genet Med"}],"container-title":["Pediatrics & Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957224001347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957224001347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T23:51:42Z","timestamp":1762559502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957224001347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1875957224001347"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2024.03.013","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into clinical phenotypes and treatment responses in a Small cohort of Taiwanese patients with SCN1A variants: A Preliminary study","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2024.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}